Singapore markets closed
  • Straits Times Index

    -4.53 (-0.14%)
  • Nikkei

    -9.83 (-0.03%)
  • Hang Seng

    +103.25 (+0.36%)
  • FTSE 100

    +45.88 (+0.65%)

    -70.58 (-0.20%)
  • CMC Crypto 200

    -17.62 (-1.87%)
  • S&P 500

    +8.26 (+0.19%)
  • Dow

    +13.36 (+0.04%)
  • Nasdaq

    +49.09 (+0.35%)
  • Gold

    -16.90 (-0.89%)
  • Crude Oil

    +0.49 (+0.70%)
  • 10-Yr Bond

    +0.0030 (+0.21%)
  • FTSE Bursa Malaysia

    -4.74 (-0.30%)
  • Jakarta Composite Index

    -12.04 (-0.20%)
  • PSE Index

    +32.08 (+0.47%)

Kathy Sherwood Joins Pelvital USA, Inc. Board of Directors

·2-min read

Pelvital USA, Inc. announces that Kathy Sherwood, Senior Vice President, Global Market Access of Inspire Medical Systems, has joined its Board of Directors.

This press release features multimedia. View the full release here:

Kathy Sherwood Joins Pelvital Board of Directors (Photo: Business Wire)

Kathy is a seasoned medical device professional with 30+ years of industry experience including urology & pelvic health, cardiac rhythm management, neurology, obstructive sleep apnea, wound care, and diagnostics with experience in R&D, operations, sales, marketing, and market access & reimbursement. Her work experience, which includes a diverse group of medical product companies such as Boston Scientific, American Medical Systems, St. Jude Medical, Kinetic Concepts, Transoma Medical and Medtronic, gives her an understanding of the problems faced by both large and small companies. She has both U.S. and international experience having lived in the Netherlands for several years, leading a European market access and reimbursement function. In Kathy’s current position at Inspire Medical, Kathy has successfully led efforts to penetrate the market with a new technology to address an unmet and underserved need in obstructive sleep apnea.

"Women I know are suffering in silence from stress urinary incontinence. It is a large, rapidly growing and largely underserved market that affects the quality of people’s lives. The world needs better solutions, and I am very impressed with the clinical outcomes of the work done by the original inventors in Norway and the Pelvital team. I am confident we can help women around the world to regain control of their lives," Sherwood said. "I am very pleased to be joining the Pelvital Board and to help bring this new technology to women."

"With extensive experience in direct-to-consumer and clinical marketing, reimbursement, pricing, and commercialization across multiple medical device companies, Kathy is uniquely qualified to help Pelvital transition from a development company into a commercialization company," said Dale Wahlstrom, CEO of Pelvital. "We look forward to Kathy providing guidance to the Pelvital team as we bring the FlyteTM incontinence product to market."

Kathy holds a Bachelor of Science degree in Mechanical-Industrial Engineering from the University of Illinois, Urbana-Champaign, and an MBA from the University of Minnesota, Carlson School of Management in Minneapolis. She is active in outdoor sports and an involved supporter of charity organizations including the Children’s Hospital Guild and Habitat for Humanity.

About Pelvital

Pelvital is a privately held company founded in 2016 and headquartered in Minneapolis, Minnesota. Its vision is to improve the lives of people who suffer from pelvic floor disorders. The company is currently beginning commercialization of the FlyteTM in-home pelvic floor treatment device, a product designed as a conservative solution for stress urinary incontinence. For more information about Pelvital and Flyte, please visit

View source version on


Dale Wahlstrom